UK starts mass COVID vaccination programme today - Newstrends
Connect with us

Health

UK starts mass COVID vaccination programme today

Published

on

Britain on Tuesday recorded a turning point in the fight against the coronavirus pandemic, as it began the biggest vaccination programme in the country’s history with a new COVID-19 jab.

The first patients in line on what has been dubbed “V-Day” — the over-80s, care home workers and at-risk frontline health and social care staff — will roll up their sleeves for an initial dose from early morning.

They will then require a second jab in 21 days’ time.

Last week Britain became the first country to approve the Pfizer-BioNTech vaccine, raising hopes of a breakthrough in the pandemic, which has killed more than 1.5 million worldwide.

Britain has been one of the worst-affected countries in the world, with more than 61,000 deaths in the outbreak from 1.6 million cases.

Prime Minister Boris Johnson, who spent days in intensive care with Covid-19 earlier this year, called it a “huge step forward in the UK’s fight against coronavirus”.

UK Health Secretary Matt Hancock, who has offered to have the jab on live television to allay public fears, said the roll-out was a “key moment” that would protect the most vulnerable.

The head of the state-run National Health Service in England, Simon Stevens, said it was a “decisive turning point” against the “greatest health challenge” since the NHS was founded in 1948.

Regulatory approval for the vaccine was given last Wednesday, sparking a race against time to prepare scores of vaccination centres across the country.

The UK has ordered 40 million doses of the jab — enough to vaccinate 20 million people — with 800,000 in the first batch.

Up to four million doses are expected by the end of December.

Queen could lead way

The mass vaccination drive is a coordinated response by all four nations of the UK — England, Scotland, Wales and Northern Ireland — which normally set their own health policies.

The public has been largely favourable to the rapid approval of the vaccine, but ministers and health professionals are aware they still need to combat mistrust.

 

The independent Medicines and Healthcare products Regulatory Agency maintains that no corners were cut and its assessment and approval procedures met stringent international norms.

NHS England said thousands had already been given the jab during trials with no serious side effects.

Nevertheless, it has been reported Queen Elizabeth II, who at 94 is among those first in the line for the vaccination because of her age, could front a public awareness campaign urging compliance.

The government said it will hand out vaccine cards to remind people to get the booster after three weeks, but insisted it was not introducing immunity certificates.

The chief medical officers of England, Scotland, Wales and Northern Ireland said the vaccine will as a result only have a “marginal impact” on hospital numbers over the winter months.

Johnson called for patience and urged the public to stick to strict social distancing guidelines to prevent a spike in cases, particular as rules are relaxed over Christmas.

 

Health officials have already run into a logistical headache about how to administer the vaccine to elderly or infirm care home residents.

The vaccine needs to be stored at -70 degrees Celsius (-94 Fahrenheit), leaving hospitals and other medical hubs as the only places able to deal with such ultra-low temperatures.

With the Pfizer-BioNTech drug made in Belgium, concerns have also been raised about potential disruption to supply when Britain leaves the European Union’s single market and customs union.

 

But the UK government said the military is on stand-by to air-lift the vaccine if there is any border disruption from January 1.

The bulk of Britain’s vaccine requirements are expected to be met by a jab developed by AstraZeneca and the University of Oxford, which is awaiting regulatory approval.

The government has ordered an initial 100 million doses of the drug, which is cheaper to manufacture, and easier to store and transport using conventional fridges.

-AFP

Health

Nigeria to Receive Breakthrough HIV Prevention Drug This Month – NACA

Published

on

HIV-AIDS

Nigeria to Receive Breakthrough HIV Prevention Drug This Month – NACA

Nigeria is set to receive Lenacapavir, a groundbreaking HIV prevention drug, in March 2026, the National Agency for the Control of AIDS (NACA) has announced.

The agency disclosed that regulatory approval has been granted by the National Agency for Food and Drug Administration and Control (NAFDAC), clearing the way for the drug’s introduction and nationwide rollout. The confirmation was contained in a statement issued on Monday by Toyin Aderibigbe, Head of Public Relations at NACA.

Lenacapavir, a long-acting injectable HIV prevention drug, has demonstrated 100 percent effectiveness in preventing HIV infection during advanced clinical trials. Unlike daily oral pre-exposure prophylaxis (PrEP) pills, the injectable medication is administered only twice a year, offering a more convenient and discreet prevention option.

NACA said the Federal Government has intensified preparations for the rollout of injectable PrEP in Nigeria, describing the initiative as a critical step toward reducing new HIV infections and strengthening national prevention strategies.

According to the agency, Lenacapavir will be made available at an affordable annual cost of about $40 per person, following voluntary licensing agreements with generic manufacturers. This pricing structure will apply across Nigeria and 119 other low- and middle-income countries, significantly expanding access to the drug.

READ ALSO:

“The Government of Nigeria is advancing preparations for the introduction and rollout of lenacapavir as pre-exposure prophylaxis (PrEP). This underscores our commitment to strengthen HIV prevention and accelerate progress toward epidemic control,” the statement said.

As part of readiness efforts, NACA revealed that landscape and preparedness assessments have been completed in 10 states — Akwa Ibom, Anambra, Benue, Cross River, Ebonyi, Gombe, Kano, Kwara, Lagos, and the Federal Capital Territory (FCT) — alongside regulatory clearance by NAFDAC.

Nigeria currently has an estimated 1.9 million people living with HIV, with a national prevalence rate of 1.3 percent among adults aged 15 to 49. In 2021, the country recorded 74,000 new HIV infections and 51,000 AIDS-related deaths, according to official data.

Women aged 15 to 49 are more than twice as likely as men to be living with HIV, while the South-South region bears the highest burden, with an HIV prevalence rate of 3.1 percent.

Health authorities say the arrival of Lenacapavir in Nigeria could mark a major turning point in HIV prevention, particularly for high-risk populations, as the country intensifies efforts to achieve long-term epidemic control.

Nigeria to Receive Breakthrough HIV Prevention Drug This Month – NACA

Continue Reading

Health

Popular Brain Supplement Amino Acid May Reduce Longevity in Men

Published

on

Popular Brain Supplement Amino Acid May Reduce Longevity in Men

Popular Brain Supplement Amino Acid May Reduce Longevity in Men

A massive study of more than 270,000 people has revealed that higher blood levels of tyrosine, a common amino acid found in protein-rich foods and popular focus-boosting supplements, are associated with shorter life expectancy in men. Researchers suggest that men with elevated tyrosine levels could live nearly one year less on average than those with lower levels, sparking questions about the long-term health effects of both diet and supplements.

The study, led by scientists from the University of Hong Kong and the University of Georgia, analyzed health, genetic, and biochemical data from participants in the UK Biobank, one of the largest population-based studies in the world. The researchers focused on tyrosine and phenylalanine, two amino acids essential to metabolism and neurotransmitter production, including dopamine, which plays a key role in mood, motivation, and cognitive performance.

READ ALSO:

Using observational and genetic modeling techniques, the researchers found that while phenylalanine had no consistent effect on lifespan, tyrosine showed a clear and potentially causal link to reduced life expectancy in men. No similar association was observed in women, suggesting that biological and hormonal differences may influence how tyrosine affects aging in men versus women.

Scientists are still investigating why tyrosine might impact longevity. One possible explanation is insulin resistance, a risk factor for age-related diseases, which tyrosine may influence. Another theory involves stress-related neurotransmitters and hormonal pathways that may react differently in men, potentially explaining why the effect was sex-specific.

Although the study did not directly test tyrosine supplements, it raises questions about their long-term safety, particularly for men who may already have high systemic levels. Nutrition experts advise moderation and recommend monitoring protein intake. Common dietary sources of tyrosine include beef, pork, lamb, chicken, turkey, salmon, tuna, mackerel, shrimp, lobster, eggs, dairy, soy, whole grains, nuts, and seeds.

The researchers emphasized the need for further studies to confirm these findings, understand the mechanisms linking tyrosine to male longevity, and explore whether dietary or lifestyle interventions could safely reduce tyrosine levels and promote healthy aging.

Popular Brain Supplement Amino Acid May Reduce Longevity in Men

Continue Reading

Health

Labour Unions Barricade NAFDAC Lagos Office Over Sachet Alcohol Ban

Published

on

Labour Unions Barricade NAFDAC Lagos Office Over Sachet Alcohol Ban

Labour Unions Barricade NAFDAC Lagos Office Over Sachet Alcohol Ban

Hundreds of workers and union members under the Nigeria Labour Congress (NLC), Trade Union Congress (TUC), and Food, Beverage and Tobacco Senior Staff Association (FOBTOB) barricaded the NAFDAC office in Isolo, Lagos on Thursday, marking the seventh consecutive day of protests over the enforcement of the sachet alcohol ban. The demonstration disrupted normal operations, with protesters blocking access to the NAFDAC premises from early morning, chanting slogans such as “No work for us, no work for you”, and demanding the immediate reopening of sealed factories, depots, and warehouses nationwide. Police officers intervened mid-morning to restore access, but union leaders vowed to continue their action until all demands are met.

The protest stems from NAFDAC’s enforcement of the ban on sachet alcohol and 10cl PET bottled products, which has led to the closure of several indigenous factories, depots, and warehouses. Union leaders argue that entire facilities — including those producing lawful products — are being shut down unnecessarily, a move they describe as “calculated economic suffocation.” Anthony Oyaga, TUC Secretary, stated: “Across the country, indigenous manufacturing companies are being sealed. Factories are being shut down. Depots are being closed. Warehouses are being locked — including those containing other lawful products not connected to the targeted items.” Protesters warned that prolonged shutdowns are threatening livelihoods, affecting not only factory workers but also transporters, suppliers, distributors, market women, artisans, and logistics personnel. They stressed that such measures could push vulnerable youths into poverty, fuel social vices, and even pose national security risks if the situation persists.

READ ALSO:

Union leaders, including FOBTOB National Secretary Jeffery Igein, emphasised that the protests would continue until the government addresses the economic fallout of factory closures and replaces strict enforcement with targeted regulatory measures. “We are not criminals. We are workers. We are producers. We are parents. We are taxpayers. We are Nigerians,” Igein said, stressing that the protests are peaceful and lawful.

NAFDAC, led by Prof. Mojisola Adeyeye, has maintained that it has not received any official directive from the federal government to suspend enforcement. The Federal Ministry of Health and Social Welfare also affirmed that NAFDAC has the exclusive legal mandate to regulate food and drug products, including sachet alcohol. Despite this, union leaders continue to demand dialogue with policymakers and the reopening of factories, depots, and warehouses, arguing that blanket enforcement has caused unnecessary economic hardship.

The protests underscore ongoing tension in Nigeria between public health policies and economic livelihoods, highlighting the delicate balance regulators face in enforcing bans while preserving jobs and sustaining industries. Workers insist that they will maintain pressure until what they call economic strangulation is reversed and structured regulation replaces punitive closures.

Labour Unions Barricade NAFDAC Lagos Office Over Sachet Alcohol Ban

Continue Reading
HostArmada Affordable Cloud SSD Shared Hosting
HostArmada - Affordable Cloud SSD Web Hosting

Trending